ArticlePediatrics2013
Incidence of childhood and adolescent melanoma in the United States: 1973-2009.
Article in Pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
50 citing papers in PubMed, 172 citations in OpenAlex.
- Global Trends in Sun Safety and Skin Cancer Prevention Education Among Adolescents: A Bibliometric Analysis.Cureus · 2026Review
- Pediatric Plantar Malignant Melanoma, Subungual Melanoma, and Spitzoid Melanoma: A Case Series of Rare Pediatric Melanomas.The Journal of clinical and aesthetic dermatology · 2026Article
- Pediatric melanoma in Arizona: Demographic, tumor, and treatment characteristics from the Arizona cancer registry.JAAD international · 2026Article
- Illuminating the Connection: Cutaneous Vitamin DNutrients · 2025Review
- Recent global patterns in skin cancer incidence, mortality, and prevalence.Chinese medical journal · 2025Article
- Immune checkpoint inhibitors in pediatric patients with melanoma: a systematic literature review.Melanoma management · 2024Review
- Regional lymph node evaluation in pediatric conventional melanoma subtype: a single-center 10-year review.Pediatric surgery international · 2024Article
- Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study.Dermatology practical & conceptual · 2024Article
- Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective.EJC paediatric oncology · 2023Article
- Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019.Journal of the National Cancer Institute · 2023Article
- The Family Lifestyles, Actions and Risk Education (FLARE) study: Protocol for a randomized controlled trial of a sun protection intervention for children of melanoma survivors.Contemporary clinical trials · 2023Article
- Projecting the number of new HIV infections to formulate the "Getting to Zero" strategy in Illinois, USA.Mathematical biosciences and engineering : MBE · 2021Article
- Clinical and Demographic Profile of Cutaneous Melanoma: Pakistani Perspective.World journal of plastic surgery · 2020Article
- Estimation of Individual Exposure to Erythemal Weighted UVR by Multi-Sensor Measurements and Integral Calculation.Sensors (Basel, Switzerland) · 2020Article
- Understanding Skin Screening Practices Among Children at Elevated Risk for Melanoma to Inform Interventions for Melanoma Prevention and Control.Journal of cancer education : the official journal of the American Association for Cancer Education · 2020Article
- Age-Specific Incidence of Melanoma in the United States.JAMA dermatology · 2020Observational
- A characterization of sun protection attitudes and behaviors among children and adolescents in the United States.Preventive medicine reports · 2019Article
- Imaging of pediatric cutaneous melanoma.Pediatric radiology · 2019Review
- Malignant melanoma incidence among children and adolescents in Texas and SEER 13, 1995-2013.Pediatric blood & cancer · 2019Article
- Parent and child perspectives on perceived barriers to child sun protection and their association with sun protection strategies among children of melanoma survivors.Pediatric dermatology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveChildhood and adolescent melanoma is rare but has been increasing. To gain insight into possible reasons underlying this observation, we analyzed trends in melanoma incidence diagnosed between the ages of 0 and 19 years among US whites by gender, stage, age at diagnosis, and primary site. We also investigated incidence trends by UV-B exposure levels.
methodsBy using Surveillance, Epidemiology, and End Results (SEER) program data (1973-2009), we calculated age-adjusted incidence rates (IRs), annual percent changes, and 95% confidence intervals for each category of interest. Incidence trends were also evaluated by using joinpoint and local regression models. SEER registries were categorized with respect to low or high UV-B radiation exposure.
resultsFrom 1973 through 2009, 1230 children of white race were diagnosed with malignant melanoma. Overall, pediatric melanoma increased by an average of 2% per year (95% confidence interval, 1.4%-2.7%). Girls, 15- to 19-year-olds, and individuals with low UV-B exposure had significantly higher IRs than boys, younger children, and those living in SEER registries categorized as high UV-B. Over the study period, boys experienced increased IRs for melanoma on the face and trunk, and females on the lower limbs and hip. The only decreased incidence trend we observed was among 15- to 19-year-olds in the high UV-B exposure group from 1985 through 2009. Local regression curves indicated similar patterns.
conclusionsThese results may help elucidate possible risk factors for adolescent melanoma, but additional individual-level studies will be necessary to determine the reasons for increasing incidence trends.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.